Management of Concomitant Cancer and Abdominal Aortic Aneurysm

Table 1

Prevalence of aortic aneurysm and concomitant malignancy.

Source	AAA	Malignant disease	Colorectal cancer	Observation period, yr
Szilagyi et al.,1967 [4]*	803	31 (3.9)	9 (1.2)	22
Nora et al., 1989 [5]	3500	NA (the emphasis is on CRC)	17 (0.5) (those underwent operations for Ca and AAA)	12
Morris and Colquitt, 1988 [6]	158 (looking at all but with histologically proven ca)	20 (12.7)	6 (3.8)	12
Tennant 1990 [7]	247	4 (1.6)	0	5
Oshodi et al., 2000 [8]	676	8 (1.2)	4 (0.6)	20
Tsuji et al., 1999 [9]	162	4 (2.5)	1 (0.6)	10
Matsumoto et al., 2002 [10]	260	29 (11.2)	16 (6.2)	14
Baxter et al., 2002 [11]	10 872	NA	83 (0.8)	15
Yamamoto et al. [12]	408 (using FOB to detect CRC)	—	6 (1.5%) with cancer and 16 (3.9) with polyps	—
Onohara et al. [13]	112	16 (14%)	—	—

*This study was performed in the pre CT/Duplex era and therefore unlikely to detect cancer. AAA: abdominal aortic aneurysm. CRC: colorectal cancer. NA: not applicable. FOB: faecal occult blood.